Search Within

CEREBELLAR DISEASES

Anti-Oxidant Drugs: Novelties and Clinical Implications in Cerebellar Ataxias

Journal: Current Neuropharmacology
Volume: 17, Issue: 1
Page: 21-32
Authors: Emanuele Barca*, Valentina Emmanuele, Salvatore DiMauro, Antonio Toscano and Catarina M. Quinzii

Aminopyridines and Acetyl-DL-leucine: New Therapies in Cerebellar Disorders

Journal: Current Neuropharmacology
Volume: 17, Issue: 1
Page: 7-13
Authors: Roger Kalla and Michael Strupp*

Update on the Regulation of HIPK1, HIPK2 and HIPK3 Protein Kinases by microRNAs

Journal: MicroRNA
Volume: 7, Issue: 3
Page: 178-186
Authors: Andrea Conte and Giovanna Maria Pierantoni*

Physiological and Morphological Principles Underpinning Recruitment of the Cerebellar Reserve

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 17, Issue: 3
Page: 184-192
Authors: Shinji Kakei*, Takahiro Ishikawa, Jongho Lee, Takeru Honda and Donna S. Hoffman

Calcium Signaling, PKC Gamma, IP3R1 and CAR8 Link Spinocerebellar Ataxias and Purkinje Cell Dendritic Development

Journal: Current Neuropharmacology
Volume: 16, Issue: 2
Page: 151-159
Authors: Etsuko Shimobayashi * and Josef P. Kapfhammer